Keystone Investors PTE Ltd. Makes New Investment in SPDR S&P Biotech ETF $XBI

Keystone Investors PTE Ltd. purchased a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 98,600 shares of the exchange traded fund’s stock, valued at approximately $12,022,000. SPDR S&P Biotech ETF comprises approximately 1.1% of Keystone Investors PTE Ltd.’s holdings, making the stock its 22nd largest position. Keystone Investors PTE Ltd. owned 0.15% of SPDR S&P Biotech ETF at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Intesa Sanpaolo Wealth Management purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth $30,000. Legacy Wealth Managment LLC ID purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth $32,000. Greykasell Wealth Strategies Inc. purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth $35,000. Ballast Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth $36,000. Finally, Creative Financial Designs Inc. ADV purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth $39,000.

SPDR S&P Biotech ETF Trading Up 0.8%

NYSEARCA XBI opened at $133.79 on Friday. The company has a fifty day simple moving average of $132.63 and a two-hundred day simple moving average of $127.12. The stock has a market cap of $8.54 billion, a P/E ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 12-month low of $80.90 and a 12-month high of $139.19.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.